期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 16, 期 10, 页码 23651-23667出版社
MDPI
DOI: 10.3390/ijms161023651
关键词
chromatin; epigenetic regulation; gene regulation; heart disease; non-coding RNAs
资金
- Georgia Regents University Diabetes and Obesity Discovery Institute Scholar Program
- American Heart Association [12GRNT12100048]
- National Institutes of Health [R01 HL124251]
- Scientist Development Grant [14SDG18970040]
Cardiovascular disease is the leading cause of death in the United States, accounting for nearly one in every seven deaths. Over the last decade, various targeted therapeutics have been introduced, but there has been no corresponding improvement in patient survival. Since the mortality rate of cardiovascular disease has not been significantly decreased, efforts have been made to understand the link between heart disease and novel therapeutic targets such as non-coding RNAs. Among multiple non-coding RNAs, long non-coding RNA (lncRNA) has emerged as a novel therapeutic in cardiovascular medicine. LncRNAs are endogenous RNAs that contain over 200 nucleotides and regulate gene expression. Recent studies suggest critical roles of lncRNAs in modulating the initiation and progression of cardiovascular diseases. For example, aberrant lncRNA expression has been associated with the pathogenesis of ischemic heart failure. In this article, we present a synopsis of recent discoveries that link the roles and molecular interactions of lncRNAs to cardiovascular diseases. Moreover, we describe the prevalence of circulating lncRNAs and assess their potential utilities as biomarkers for diagnosis and prognosis of heart disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据